Position in FULC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,478,567
-$542,669 QoQ
Shares Held
453,529
+27.6% QoQ
Ownership
0.681%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#30
of 168 holders
Holding Since
Sep 2022
6 quarters on record
Voting authority
Sole 91.03717733595867.ToString("F0")%
Shared 0.ToString("F0")%
None 8.96282266404133.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Trexquant Investment LP holds $496,284,960 across 119 Biotechnology names. FULC ranks #53 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
483,971 | $24,585,726 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
61,760 | $20,434,531 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
277,114 | $17,375,047 | |
| 4 | EXEL |
Exelixis, Inc.
|
390,818 | $16,762,184 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
594,850 | $16,661,748 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
213,645 | $16,042,603 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
390,951 | $15,528,573 | |
| 8 | ASND |
Ascendis Pharma A/S
|
65,517 | $14,985,703 |
All Filings in FULC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,478,567 | 453,529 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,021,236 | 355,547 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $193,338 | 21,015 | Shares | Sole | 2025-11-14 | |
| 2024-06-30 | $437,137 | 70,506 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $445,775 | 47,222 | Shares | Sole | 2024-05-14 | |
| 2022-09-30 | $112,337 | 13,886 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||